scholarly article | Q13442814 |
P50 | author | Meghna Talekar | Q56942818 |
Parin Shah | Q86942811 | ||
P2093 | author name string | Mansoor M Amiji | |
Srujan Gandham | |||
Malav Trivedi | |||
Adwait Oka | |||
Qijun Ouyang | |||
P2860 | cites work | Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors | Q27302811 |
Macrophage repolarization with targeted alginate nanoparticles containing IL-10 plasmid DNA for the treatment of experimental arthritis | Q27329759 | ||
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship | Q28278682 | ||
Tumour-educated macrophages promote tumour progression and metastasis | Q29614307 | ||
Nanocarriers as an emerging platform for cancer therapy | Q29616699 | ||
Restoration of p53 function leads to tumour regression in vivo | Q29618727 | ||
Morphine induces redox-based changes in global DNA methylation and retrotransposon transcription by inhibition of excitatory amino acid transporter type 3-mediated cysteine uptake | Q30413204 | ||
Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase | Q30490786 | ||
Therapeutic cancer targeting peptides | Q33184888 | ||
Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics | Q33228215 | ||
Small RNA combination therapy for lung cancer | Q34120092 | ||
MicroRNA regulation and therapeutic targeting of survivin in cancer | Q34991312 | ||
MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways | Q35028282 | ||
Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer | Q35089242 | ||
MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer. | Q35089472 | ||
Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer | Q35374920 | ||
M2-Polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma | Q35473223 | ||
MicroRNA-125b potentiates macrophage activation | Q35523881 | ||
Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian Cancer | Q35836455 | ||
Macrophages in Tumor Microenvironments and the Progression of Tumors | Q36065902 | ||
MicroRNAs in immune response and macrophage polarization. | Q36547119 | ||
EGFR-targeted therapy for non-small cell lung cancer: focus on EGFR oncogenic mutation | Q36619212 | ||
Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors | Q36795709 | ||
Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer. | Q37065575 | ||
In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles | Q37381483 | ||
Nucleic acid therapeutics: concepts for targeted delivery to solid tumors | Q38027844 | ||
Good guy or bad guy: the opposing roles of microRNA 125b in cancer | Q38207752 | ||
Tumor-associated macrophages as major players in the tumor microenvironment | Q38240110 | ||
The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer | Q38858580 | ||
MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression | Q39403675 | ||
MicroRNA-125b is a novel negative regulator of p53. | Q39871732 | ||
Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer | Q41969702 | ||
A network comprising short and long noncoding RNAs and RNA helicase controls mouse retina architecture | Q42429977 | ||
Modulation of Macrophage Functional Polarity towards Anti-Inflammatory Phenotype with Plasmid DNA Delivery in CD44 Targeting Hyaluronic Acid Nanoparticles | Q43168468 | ||
Small Cell Lung Cancer | Q60307382 | ||
Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor | Q71961895 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | nanoparticle | Q61231 |
lung cancer | Q47912 | ||
microRNA | Q310899 | ||
P304 | page(s) | 759-769 | |
P577 | publication date | 2015-12-21 | |
P1433 | published in | Molecular Therapy | Q15762400 |
P1476 | title | Combination wt-p53 and MicroRNA-125b Transfection in a Genetically Engineered Lung Cancer Model Using Dual CD44/EGFR-targeting Nanoparticles | |
P478 | volume | 24 |
Q37013417 | Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models |
Q64968892 | Functionalized MoS2-erlotinib produces hyperthermia under NIR. |
Q43837554 | LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells |
Q33808084 | MicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells. |
Q58786519 | MicroRNA-524 promotes cell proliferation by down-regulating PTEN expression in osteosarcoma |
Q92392214 | MicroRNAs in tumor immunity: functional regulation in tumor-associated macrophages |
Q37224277 | Modification of tumor cell exosome content by transfection with wt-p53 and microRNA-125b expressing plasmid DNA and its effect on macrophage polarization. |
Q54231141 | Non-Viral Based miR Delivery and Recent Developments |
Q50054196 | Paclitaxel inhibits breast cancer metastasis via suppression of Aurora kinase-mediated cofilin-1 activity |
Q33824400 | Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment |
Q55519016 | RNaseT2 knockout rats exhibit hippocampal neuropathology and deficits in memory. |
Q55379182 | miR-19 in blood plasma reflects lung cancer occurrence but is not specifically associated with radon exposure. |
Q88301412 | miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6 |
Q52590768 | miRNAs in Tuberculosis: New Avenues for Diagnosis and Host-Directed Therapy. |
Search more.